Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, Tyler J., Wei, Shuang, Dong, Haidong, Alvarez, Xavier, Cheng, Pui, Mottram, Peter, Krzysiek, Roman, Knutson, Keith L. +14 more·2003·Nature Medicine

DOI 10.1038/nm863

Cited by (1,000)

Items 101–200 of 1,000

Bone Marrow Is a Reservoir for CD4+CD25+ Regulatory T Cells that Traffic through CXCL12/CXCR4 Signals
Linhua Zou, Brian G. Barnett, Hana F Safah, Vincent F. LaRussa, Melina Evdemon-Hogan, Peter J. Mottram, Shuang Wei, Odile David, Tyler Jay Curiel, Weiping Zou · 2004 · Cancer Research
Strategies for use of IL‐10 or its antagonists in human disease
Anne O’Garra, Franck J. Barrat, António G. Castro, Alain P. Vicari, Catherine M. Hawrylowicz · 2008 · Immunological Reviews
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
Katy Milne, Martin Köbel, Steven E. Kalloger, Rebecca O. Barnes, Dongxia Gao, C. Blake Gilks, Peter Hamilton Watson, Brad H. Nelson · 2009 · PLoS ONE
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Wei Li, Takashi Tanikawa, Ilona Kryczek, Houjun Xia, Gaopeng Li, Ke Wu, Shuang Wei, Lili Zhao, Linda Vatan, Bo Wen et al. · 2018 · Cell Metabolism
Interferon regulatory factor‐1 is prerequisite to the constitutive expression and IFN‐γ‐induced upregulation of B7‐H1 (CD274)
Seung Jin Lee, Byeong‐Churl Jang, Soo-Woong Lee, Young‐Il Yang, Seong‐Il Suh, Yeong-Min Park, Sangtaek Oh, Jae‐Gook Shin, Sheng Yao, Lieping Chen et al. · 2006 · FEBS Letters
Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features
Julien Caldéraro, Benoı̂t Rousseau, Giuliana Amaddeo, Marion Mercey-Ressejac, Cécile Charpy, Charlotte E. Costentin, Alain Luciani, Elie‐Serge Zafrani, Alexis Laurent, Daniel Azoulay et al. · 2016 · Hepatology
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Jo Marie Tran Janco, Purushottam Lamichhane, Lavakumar Karyampudi, Keith L. Knutson · 2015 · The Journal of Immunology
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
Raoul Andre Droeser, Christian Hirt, Carsten Thomas Viehl, Daniel M. Frey, Christian Andreas Nebiker, Xaver Huber, Inti Zlobec, Serenella Eppenberger‐Castori, Alexandar Tzankov, Raffaele Rosso et al. · 2013 · European Journal of Cancer
Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
Tracy Xiao Cui, Ilona Kryczek, Lili Zhao, Ende Zhao, Rork D. Kuick, Michael H. Roh, Linda Vatan, Wojciech Szeliga, Yujun Mao, Dafydd G. Thomas et al. · 2013 · Immunity
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Weimin Wang, Ilona Kryczek, Lubomír Dostál, Heng Lin, Lijun Tan, Lili Zhao, Fujia Lu, Shuang Wei, Tomasz Maj, Dongjun Peng et al. · 2016 · Cell
CXCL12 and Vascular Endothelial Growth Factor Synergistically Induce Neoangiogenesis in Human Ovarian Cancers
Ilona Kryczek, Andrzej Lange, Peter J. Mottram, Xavier A. Alvarez, Pui Joan Cheng, Melina Evdemon-Hogan, Lieve Moons, Shuang Wei, Linhua Zou, Véronique Machelon et al. · 2005 · Cancer Research
Anti-angiogenic therapy: current challenges and future perspectives
Lopes-Coelho, Filipa, Martins, Filipa, Pereira, Sofia A., Serpa, Jacinta · 2021 · International Journal of Molecular Sciences
Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment
Ilona Kryczek, Shuang Wei, Linhua Zou, Saleh Altuwaijri, Wojciech Szeliga, Jay K. Kolls, Alfred E. Chang, Weiping Zou · 2007 · The Journal of Immunology
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
Long Zhang, Thomas Frank Gajewski, Justin Paul Kline · 2009 · Blood
Autophagy in tumour immunity and therapy
Houjun Xia, Douglas R. Green, Weiping Zou · 2021 · Nature reviews. Cancer
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
Zhao, Ende, Maj, Tomasz, Kryczek, Ilona, Li, Wei, Wu, Ke, Zhao, Lili, Wei, Shuang, Crespo, Joel, Wan, Shanshan, Vatan, Linda et al. · 2016 · Nature Immunology
Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
Jiabei He, Ying Hu, Mingming Hu, Baolan Li · 2015 · Scientific Reports
Endogenous IL-17 contributes to reduced tumor growth and metastasis
Ilona Kryczek, Shuang Wei, Wojciech Szeliga, Linhua Vatan, Weiping Zou · 2009 · Blood
Interleukin-10 and the immune response against cancer: a counterpoint
Simone Mocellin M. D, Francesco Maria Marincola, Howard A. Young · 2005 · Journal of Leukocyte Biology
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
Muhammad Zaeem Noman, Meriem Hasmim, Yosra Messai, Stéphane Terry, Claudine Kiéda, Bassam Janji, Salem Chouaı̈b · 2015 · American Journal of Physiology-Cell Physiology
Programmed death ligand 1 signals in cancer cells
Anand V. R. Kornepati, Ratna K. Vadlamudi, Tyler Jay Curiel · 2022 · Nature reviews. Cancer
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
Curtis A. Clark, Harshita B. Gupta, Gangadhara R. Sareddy, Srilakshmi Pandeswara, Shunhua Lao, Bin Yuan, Justin Michael Drerup, Alvaro Souto Padron, Jose Ramon Conejo-Garcia, Kruthi Murthy et al. · 2016 · Cancer Research
IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L
Ilona Kryczek, Yanwei Lin, Nisha Nagarsheth, Dongjun Peng, Lili Zhao, Ende Zhao, Linda Vatan, Wojciech Szeliga, Yali Dou, Scott R. Owens et al. · 2014 · Immunity
Regulatory T Cells in Cancer
Dimitrios Mougiakakos, Aniruddha Choudhury, Álvaro Lladser, Rolf W. Kiessling, C. Christian Johansson · 2010 · Advances in cancer research
Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
Anna C. Filley, Mario A. Henriquez, Mahua Dey · 2017 · Oncotarget
Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions
Wu, Ke, Kryczek, Ilona, Chen, Lieping, Zou, Weiping, Welling, Theodore H. · 2009 · Cancer Research
Plasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma
Shuang Wei, Ilona Kryczek, Linhua Zou, Ben Daniel, Pui Joan Cheng, Peter J. Mottram, Tyler Jay Curiel, Andrzej Lange, Weiping Zou · 2005 · Cancer Research
At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
Andrew M. Intlekofer, Craig B. Thompson · 2013 · Journal of Leukocyte Biology
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, Milad Ashrafizadeh, Amir Reza Aref, Israel Cañadas, Yu Tian, Xiaojia Niu, Yuzhuo Z. Wang, Pedram Torabian et al. · 2024 · Journal of Hematology & Oncology
PD-1 is a novel regulator of human B-cell activation
Thibult, Marie-Laure, Mamessier, Emilie, Gertner-Dardenne, Julie, Pastor, Sonia, Just-Landi, Sylvaine, Xerri, Luc, Chetaille, Bruno, Olive, Daniel · 2013 · International Immunology
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
C. Kuo, Ananth Ponneri Babuharisankar, Ying-Chen Lin, Hui-Wen Lien, Yu-Kang Lo, Han-Yu Chou, Vidhya Tangeda, Li-Chun Cheng, A. Cheng, A. Lee · 2022 · Journal of Biomedical Sciences
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
Tae Kon Kim, Esten N. Vandsemb, Roy S. Herbst, Lieping Chen · 2022 · Nature Reviews Drug Discovery
PD-L1 and Survival in Solid Tumors: A Meta-Analysis
Pin Wu, Dang Wu, Li‐Jun Li, Ying Chai, Jian Huang · 2015 · PLoS ONE
PD-1hi identifies a novel regulatory b-cell population in human hepatoma that promotes disease progression
Xiao, Xiao, Lao, Xiang-Ming, Chen, Min-Min, Liu, Rui-Xian, Wei, Yuan, Ouyang, Fang-Zhu, Chen, Dong-Ping, Zhao, Xiao-Yu, Zhao, Qiyi, Li, Xue-Feng et al. · 2016 · Cancer Discovery
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
Jun Min Zhou, Kathleen Margaret Mahoney, Anita Giobbie‐Hurder, Fengmin Zhao, Sandra Lee, Xiaoyun Liao, Scott J. Rodig, Jingjing Li, Xinqi Wu, Lisa Helene Butterfield et al. · 2017 · Cancer Immunology Research
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Junzo Hamanishi, Masaki Mandai, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ikuo Konishi · 2016 · International Journal of Clinical Oncology
At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
Margaret K. Callahan, Jedd D. Wolchok · 2013 · Journal of Leukocyte Biology
Manipulating dendritic cell biology for the active immunotherapy of cancer
David W. O’Neill, Sylvia Adams, Nina Bhardwaj · 2004 · Blood
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
Alice L. Hung, Russell Maxwell, Debebe Theodros, Zineb Belcaid, Dimitrios Mathios, Andrew S. Luksik, Eileen S. Kim, Adela Wu, Yuanxuan Xia, Tomás Garzón-Muvdi et al. · 2018 · OncoImmunology
From mice to humans: developments in cancer immunoediting
Teng, Michele W.L., Galon, Jerome, Fridman, Wolf-Herman, Smyth, Mark J. · 2015 · Journal of Clinical Investigation
Tumor infiltrating lymphocytes in ovarian cancer
Phillip P. Santoiemma, Daniel J. Powell · 2015 · Cancer Biology & Therapy
Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity
Atsushi Kato, Robert P. Schleimer · 2007 · Current Opinion in Immunology
Relationship between B7-H4, Regulatory T Cells, and Patient Outcome in Human Ovarian Carcinoma
Ilona Kryczek, Shuang Wei, Gefeng Zhu, Leann Myers, Peter J. Mottram, Pui Joan Cheng, Lieping Chen, George Coukos, Weiping Zou · 2007 · Cancer Research
The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
Simone E. Muenst, Savas Deniz Soysal, Feng Gao, Ellen Christina Obermann, Daniel Oertli, William E. Gillanders · 2013 · Breast Cancer Research and Treatment
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function
Lee, Young-hee, Martin-Orozco, Natalia, Zheng, Peilin, Li, Jing, Zhang, Peng, Tan, Haidong, Park, Hyun Jung, Jeong, Mira, Chang, Seon Hee, Kim, Byung-Seok et al. · 2017 · Cell Research
Interferon‐γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor‐associated macrophages
Dorothée Duluc, Murielle Corvaisier, Simon Blanchard, Laurent Catala, Philippe Descamps, Erick C. Gamelin, Stéphane Ponsoda, Yves Delneste, Mohamed Hebbar, Pascale Jeannin · 2009 · International Journal of Cancer
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
Weijie Ma, Barbara M. Gilligan, Jianda D. Yuan, Tianhong Li · 2016 · Journal of Hematology & Oncology
Systemic dysfunction and plasticity of the immune macroenvironment in cancer models
Breanna M. Allen, Kamir J. Hiam-Galvez, Cassandra E. Burnett, Anthony C. Venida, Rachel DeBarge, Iliana Tenvooren, Diana M. Marquez, Nam Woo Cho, Yaron Carmi, Matthew H. Spitzer · 2020 · Nature Medicine
Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy
Keman Cheng, Yanping Ding, Ying Zhao, Shefang Ye, Xiao Zhao, Yinlong Zhang, Tianjiao Ji, Huanhuan Wu, Bin Wang, Gregory Jon Anderson et al. · 2018 · Nano Letters
Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy
Liu, Yuting, Zugazagoitia, Jon, Ahmed, Fahad Shabbir, Henick, Brian S., Gettinger, Scott N., Herbst, Roy S., Schalper, Kurt A., Rimm, David L. · 2020 · Clinical Cancer Research
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
Delphine Rossille A, M Gressier, Diane Damotte, Delphine Maucort‐Boulch, Céline Pangault, G. Sémana, Steven Le Gouill, Corinne Haïoun, Karin Tarte, T Lamy et al. · 2014 · Leukemia
Inflammatory cell infiltration of tumors: Jekyll or Hyde
James E. Talmadge, Moses K. Donkor, Eric M. Scholar · 2007 · Cancer and Metastasis Reviews
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
Yan Zhang, Ying Zhou, Jingsheng Lou, Jinbao Li, Lulong Bo, Keming Zhu, Xiaojian Wan, Xiaoming Deng, Zailong Cai · 2010 · Critical Care
Role of PD-1 in Regulating T-Cell Immunity
Hyun‐Tak Jin, Rafi Ahmed, Taku Okazaki · 2010 · Current topics in microbiology and immunology
Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer
Fernando Concha‐Benavente, Raghvendra Mohan Srivastava, Sumita Trivedi, Yu L. Lei, Uma R. Chandran, Raja R. Seethala, Gordon James Freeman, Robert Louis Ferris · 2015 · Cancer Research
Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages
Shicheng Su, Jinghua Zhao, Yue Xing, Xiaoqian Zhang, Jiang Liu, Qian Ouyang, Jianing Chen, Fengxi Su, Qiang Liu, Erwei Song · 2018 · Cell
Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy
Weimin Wang, Weiping Zou · 2020 · Molecular Cell
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
Takuro Noguchi, Jeffrey P. Ward, Matthew M. Gubin, Cora D. Arthur, Sang Hun Lee, Jasreet Hundal, Mark J. Selby, Robert F. Graziano, Elaine R. Mardis, Alan J. Korman et al. · 2017 · Cancer Immunology Research
Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses <i>in vitro</i>
Blank, Christian, Kuball, Juergen, Voelkl, Simon, Wiendl, Heinz, Becker, Bernd, Walter, Bernhard, Majdic, Otto, Gajewski, Thomas F., Theobald, Mathias, Andreesen, Reinhard et al. · 2006 · International Journal of Cancer
Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer
Tyler Jay Curiel, Pui Joan Cheng, Peter J. Mottram, Xavier A. Alvarez, Lieve Moons, Melina Evdemon-Hogan, Shuang Wei, Linhua Zou, Ilona Kryczek, Gary W. Hoyle et al. · 2004 · Cancer Research
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Zijun Yidan Xu-Monette, Mingzhi Zhang, Jianyong Li, Ken H. Young · 2017 · Frontiers in Immunology
Current status of interleukin-10 and regulatory T-cells in cancer
Dennis, Kristen L., Blatner, Nichole R., Gounari, Fotini, Khazaie, Khashayarsha · 2013 · Current Opinion in Oncology
TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
Park, Benjamin V., Freeman, Zachary T., Ghasemzadeh, Ali, Chattergoon, Michael A., Rutebemberwa, Alleluiah, Steigner, Jordana, Winter, Matthew E., Huynh, Thanh V., Sebald, Suzanne M., Lee, Se-Jin et al. · 2016 · Cancer Discovery
Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment
Amy J. Petty, Ang Li, Xinyi Wang, Rui Dai, Benjamin Michael Heyman, David S. Hsu, Xiaopei Huang, Yiping Yang · 2019 · Journal of Clinical Investigation
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities
Hack, Stephen P., Zhu, Andrew X., Wang, Yulei · 2020 · Frontiers in Immunology
Costimulatory and coinhibitory receptors in anti‐tumor immunity
Grégory Driessens, Justin Paul Kline, Thomas Frank Gajewski · 2009 · Immunological Reviews
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
Takami Sato, Mizue Terai, Yutaka Tamura, Vitali Y Alexeev, Michael J. Mastrangelo, Senthamil R. Selvan · 2011 · Immunologic Research
Human T <sub>H</sub> 17 Cells Are Long-Lived Effector Memory Cells
Kryczek, Ilona, Zhao, Ende, Liu, Yan, Wang, Yin, Vatan, Linhua, Szeliga, Wojciech, Moyer, Jeffrey, Klimczak, Aleksandra, Lange, Andrzej, Zou, Weiping · 2011 · Science Translational Medicine
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
Sergio A. Quezada, Karl S. Peggs, Tyler R. Simpson, James Patrick Allison · 2011 · Immunological Reviews
The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance
Günther Schönrich, Martin J. Raftery · 2019 · Frontiers in Cellular and Infection Microbiology
Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling
Dongjun Peng, Takashi Tanikawa, Wei Li, Lili Zhao, Linda Vatan, Wojciech Szeliga, Shanshan Wan, Shuang Wei, Yin Wang, Yan Liu et al. · 2016 · Cancer Research
Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis.
Sabine Wintterle, Bettina Schreiner, Meike Mitsdoerffer, Dagmar Schneider, Lieping Chen, Richard Meyermann, Michael Weller, Heinz Wiendl · 2003 · PubMed
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
Annie A. Wu, Virginia E. Drake, Huai-Shiuan Huang, ShihChi Chiu, Lei Zheng · 2015 · OncoImmunology
PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer
Nisha Nagarsheth, Dongjun Peng, Ilona Kryczek, Ke Wu, Wei Li, Ende Zhao, Lili Zhao, Shuang Wei, Timothy L. Frankel, Linda Vatan et al. · 2015 · Cancer Research
Combined Magnetic Hyperthermia and Immune Therapy for Primary and Metastatic Tumor Treatments
Jiong Pan, Ping Hu, Yuedong Guo, Junnian Hao, Dalong Ni, Yingying Xu, Qunqun Bao, Heliang Yao, Chenyang Wei, Qingsheng Wu et al. · 2020 · ACS Nano
Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via l -Arginine Metabolism
Lyse A. Norian, Paulo C. Rodrı́guez, Leigh A. O’Mara, Jovanny Zabaleta, Augusto C. Ochoa, Marina Cella, Paul M. Allen · 2009 · Cancer Research
Dendritic cells in cancer immunology
Theresa L. Murphy, KENNETH M. M. MURPHY · 2021 · Cellular and Molecular Immunology
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
Ilona Kryczek, Suling Liu, Michael H. Roh, Linhua Vatan, Wojciech Szeliga, Shuang Wei, Mousumi Banerjee, Yujun Mao, Jan Kotarski, Max S. Wicha et al. · 2011 · International Journal of Cancer
The Biology of Human Lymphoid Malignancies Revealed by Gene Expression Profiling
Louis M. Staudt, Sandeep S. Davé · 2005 · Advances in immunology
Novel immunotherapies in lymphoid malignancies
Connie Lee Batlevi, Eri Matsuki, Renier J. Brentjens, Anas Younes · 2015 · Nature Reviews Clinical Oncology
Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
Liping Pei, Yang Liu, Lin Liu, Shuochen Gao, Xueyan Gao, Yudi Feng, Zhenqiang Sun, Yan Zhang, Chengzeng Wang · 2023 · Molecular Cancer
Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells
Nazareth, Michael R, Broderick, Lori, Simpson-Abelson, Michelle R, Kelleher, Raymond J, Yokota, Sandra J, Bankert, Richard B · 2007 · The Journal of Immunology
Emerging Tim-3 functions in antimicrobial and tumor immunity
Kaori Sakuishi, Pushpa Jayaraman, Samuel M. Behar, Ana Carrizosa Anderson, Vijay Kumar Kuchroo · 2011 · Trends in Immunology
Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
Zachary Aaron Cooper, Vikram R. Juneja, Peter T. Sage, Dennie Tompers Frederick, Adriano Piris, Devarati Mitra, Jennifer A. Lo, Frank Stephen Hodi, Gordon James Freeman, Marcus Bosenberg et al. · 2014 · Cancer Immunology Research
Effector, Memory, and Dysfunctional CD8+T Cell Fates in the Antitumor Immune Response
John Reiser, Arnob Banerjee · 2016 · Journal of Immunology Research
An unexpected N-terminal loop in PD-1 dominates binding by nivolumab
Shuguang Tan, Hao Zhang, Yan Chai, Hao Song, Zhou Tong, Qihui Wang, Jianxun Qi, Gary Wong, Xiaodong Zhu, William J. Liu et al. · 2017 · Nature Communications
Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
James Walter Krempski, Lavakumar Karyampudi, Marshall D. Behrens, Courtney L. Erskine, Lynn C. Hartmann, Haidong Dong, Ellen L. Goode, Kimberly R. Kalli, Keith L. Knutson · 2011 · The Journal of Immunology
The tumor‐draining lymph node as an immune‐privileged site
David H. Munn, Andrew L. Mellor · 2006 · Immunological Reviews
The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle
Simone Mocellin M. D, Francesco Maria Marincola, Carlo Riccardo Rossi, Donato Nitti, Mario Lise · 2003 · Cytokine & Growth Factor Reviews
Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family
In-Hak Choi, Gefeng Zhu, Gabriel Sica, Scott Eric Strome, John C. Cheville, Julie S. Lau, Yuwen Zhu, Dallas B. Flies, Koji Tamada, Lieping Chen · 2003 · The Journal of Immunology
Genetic and Epigenetic Regulation of PD-1 Expression
Alexander P. R. Bally, James W Austin, Jeremy M. Boss · 2016 · The Journal of Immunology
The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck
Dan Paul Zandberg, Scott Eric Strome · 2014 · Oral Oncology
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal
Stefanie N. Linch, Michael J. McNamara, William L. Redmond · 2015 · Frontiers in Oncology
Interleukin‐10 suppression of myeloid cell activation — a continuing puzzle
Lynn M. Williams, Giuseppe Ricchetti, Usha Sarma, Timothy Smallie, Brian M. J. Foxwell · 2004 · Immunology
Regulatory T Cells in Ovarian Cancer: Biology and Therapeutic Potential
Brian G. Barnett, Ilona Kryczek, Pui Joan Cheng, Weiping Zou, Tyler Jay Curiel · 2005 · American Journal of Reproductive Immunology
Targeting tumor microenvironment in ovarian cancer: Premise and promise
Yuting Jiang, Chengdi Wang, Shengtao Zhou · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
Yueh-Min Lin, Wen‐Wei Sung, Ming‐Ju Hsieh, Shih-Chen Tsai, Hung‐Wen Lai, Shu-Mei Yang, Ko-Hong Shen, Mu-Kuan Chen, Huei Lee, Kun-Tu Yeh et al. · 2015 · PLoS ONE
Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment
Lucie Kopfstein, Gerhard Christofori · 2006 · Cellular and Molecular Life Sciences
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
Karl S. Peggs, Sergio A. Quezada, James Patrick Allison · 2008 · Immunological Reviews
The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity
Suzanne Ostrand‐Rosenberg, Lucas A. Horn, Samuel T. Haile · 2014 · The Journal of Immunology